Predictive Role of KLK10 and Other Neuroinflammatory Molecules on Clinical Outcomes of AIS
Clinical trial NCT06549972 · COMPLETED
Trial details
- NCT number
- NCT06549972
- Sponsor
- Ruijin Hospital
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2024-08-12
- Primary completion
- 2025-06-30
- Enrollment
- 273
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.